Recent studies provide new insights into signaling by mutant KRAS, inhibitors of which have provided modest benefits for patients. Skip to main content The New England Journal of Medicine NEJM ...

Outside-in signaling shows a route into cancer cells. ScienceDaily. Retrieved June 11, 2025 from www.sciencedaily.com / releases / 2025 / 02 / 250204173741.htm. University of California - Davis.